Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Cash from Investing Activities (2018 - 2025)

Neurogene (NGNE) has disclosed Cash from Investing Activities for 5 consecutive years, with $22.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Investing Activities rose 175.92% year-over-year to $22.0 million, compared with a TTM value of -$118.2 million through Sep 2025, down 419.61%, and an annual FY2024 reading of -$125.3 million, down 588.59% over the prior year.
  • Cash from Investing Activities was $22.0 million for Q3 2025 at Neurogene, up from $7.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $29.9 million in Q1 2024 and bottomed at -$102.6 million in Q4 2024.